David R Baldwin Selected Research

norlaudanosoline-1-carboxylic acid (NLCA)

5/2016	Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries.
1/2014	Small-cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit.
9/2013	Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit.
2/2013	The pathological confirmation rate of lung cancer in England using the NLCA database.
12/2011	Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David R Baldwin Research Topics

Disease

11	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2011
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2021 - 02/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Emphysema 01/2020
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2020
1	Chronic Cough 01/2020
1	Neoplasms (Cancer) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Hypertension (High Blood Pressure) 12/2019
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Dermatitis 10/2019
1	Adenocarcinoma 01/2016
1	Adenocarcinoma of Lung 09/2015
1	Cystic Fibrosis (Mucoviscidosis) 07/2014
1	Anorexia 07/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2002

Drug/Important Bio-Agent (IBA)

5	norlaudanosoline-1-carboxylic acid (NLCA)IBA 05/2016 - 12/2011
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
1	PlatinumIBA 04/2021
1	B7-H1 AntigenIBA 01/2020
1	GoldIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2019
1	RNA (Ribonucleic Acid)IBA 09/2015
1	Appetite StimulantsIBA 07/2014
1	ORALIT (ORS)IBA 01/2013
1	Rifampin (Rifampicin)FDA LinkGeneric 12/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 04/2021 - 01/2014
3	Radiotherapy 04/2021 - 10/2019
2	Therapeutics 01/2018 - 07/2014
1	Nebulizers and Vaporizers (Inhaler) 01/2020
1	Aftercare (After-Treatment) 11/2018
1	Palliative Care (Palliative Therapy) 01/2018
1	Time-to-Treatment 04/2015
1	Chemoradiotherapy 03/2014